Elotuzumab Intravenous and Insulin aspart protamine and insulin aspart Subcutaneous
Determining the interaction of Elotuzumab Intravenous and Insulin aspart protamine and insulin aspart Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: elotuzumab
Brand name: Empliciti
Synonyms: Elotuzumab
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: Insulin aspart and insulin aspart protamine, Insulin Aspart Protamine and Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Elotuzumab Intravenous-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Elotuzumab Intravenous-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Elotuzumab Intravenous-Insulin Aspart Protamine Injection
- Elotuzumab Intravenous-Insulin aspart, recombinant Subcutaneous
- Elotuzumab Intravenous-Insulin degludec
- Elotuzumab Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Insulin aspart protamine and insulin aspart Subcutaneous-Eloxatin
- Insulin aspart protamine and insulin aspart Subcutaneous-Elppa CoQ10 coenzyme Q-10
- Insulin aspart protamine and insulin aspart Subcutaneous-Elspar
- Insulin aspart protamine and insulin aspart Subcutaneous-Elta SilverGel
- Insulin aspart protamine and insulin aspart Subcutaneous-Elta Tar
- Insulin aspart protamine and insulin aspart Subcutaneous-Eltrombopag